1090 related articles for article (PubMed ID: 10567493)
1. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
2. A genetic register for von Hippel-Lindau disease.
Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
[TBL] [Abstract][Full Text] [Related]
3. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
[TBL] [Abstract][Full Text] [Related]
4. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.
Woodward ER; Wall K; Forsyth J; Macdonald F; Maher ER
Brain; 2007 Mar; 130(Pt 3):836-42. PubMed ID: 17264095
[TBL] [Abstract][Full Text] [Related]
5. Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau Disease.
Furness H; Salfity L; Devereux J; Halliday D; Hanson H; Ruddy DM; Uk Vhl Study Group ; Shah N; Sultana G; Woodward ER; Sandford RN; Snape KM; Maher ER
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573396
[TBL] [Abstract][Full Text] [Related]
6. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
7. Somatic mosaicism in von Hippel-Lindau Disease.
Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
[TBL] [Abstract][Full Text] [Related]
9. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
[TBL] [Abstract][Full Text] [Related]
10. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.
Hes FJ; McKee S; Taphoorn MJ; Rehal P; van Der Luijt RB; McMahon R; van Der Smagt JJ; Dow D; Zewald RA; Whittaker J; Lips CJ; MacDonald F; Pearson PL; Maher ER
J Med Genet; 2000 Dec; 37(12):939-43. PubMed ID: 11106358
[TBL] [Abstract][Full Text] [Related]
11. Multiple intracerebral haemangioblastomas in identical twins with von Hippel-Lindau disease--a clinical and molecular study.
Sobottka SB; Frank S; Hampl M; Schackert HK; Schackert G
Acta Neurochir (Wien); 1998; 140(3):281-5. PubMed ID: 9638266
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
13. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau disease: delayed presentation as a cerebellar haemangioblastoma in an elderly patient.
Shekhar H; Myles L; Lee M
Br J Neurosurg; 2009 Feb; 23(1):97-8. PubMed ID: 19234919
[TBL] [Abstract][Full Text] [Related]
15. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
16. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract][Full Text] [Related]
17. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
[TBL] [Abstract][Full Text] [Related]
18. Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Lindau tumor suppressor gene.
Fisher PG; Tontiplaphol A; Pearlman EM; Duffner PK; Hyder DJ; Stolle CA; Vortmeyer AO; Zhuang Z
Ann Neurol; 2002 Feb; 51(2):257-60. PubMed ID: 11835384
[TBL] [Abstract][Full Text] [Related]
19. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
